WARNINGMIXING OR WITHDRAWAL CAN BE DANGEROUS
Ordinary doses in combination with other depressants can fatally stop breathing. After prolonged dependency, stopping suddenly can also cause seizures or delirium; seek medical help.
Brotizolam
Brotizolam is a sedative-hypnotic of the thienotriazolodiazepine class, a benzodiazepine analog patented in 1974 and introduced into medical use in 1984.citation needed It is prescribed for short-term treatment of severe insomnia in parts of Europe, Israel, and Japan. Brotizolam is notable for its exceptional potency and rapid elimination, producing effects comparable to triazolam and midazolam. As with other benzodiazepines, it carries risks of respiratory depression when combined with other depressants, as well as amnesia and habit formation.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Brotizolam produces an experience dominated by rapid, heavy sedation and anxiety relief, consistent with its use as a highly potent, short-acting hypnotic for severe insomnia. Its character closely resembles short-acting benzodiazepines such as triazolam, with pronounced hypnotic, muscle relaxant, and amnesic components and little in the way of sensory alteration. Residual effects such as drowsiness and impaired cognitive and motor function can persist into the following day, particularly at doses above 0.5-1 mg.
Physical
The body load centers on strong sedation and skeletal muscle relaxation, accompanied by ataxia, clumsiness, slurred speech, and general impairment of motor function. Dizziness, fatigue, and headache are common, while nausea, vomiting, palpitations, hypotension, and respiratory depression occur less often.
Cognitive
The headspace is calm and anxiety-suppressed but clouded, with confusion and anterograde amnesia commonly accompanying moderate to high doses. Paradoxical reactions such as anxiety, aggression, or violent behavior occur infrequently.
Paradoxical
Paradoxical reactions occur in a minority of users.
Suppressions
Suppressive effects dominate the mental state, in line with the compound's hypnotic and anxiolytic profile.
Visual
Visual effects are not a typical feature of brotizolam.
Pharmacology
Pharmacodynamics
Brotizolam acts as a positive allosteric modulator of the GABA-A receptor at the benzodiazepine binding site.citation needed Through this mechanism, it produces anxiolytic, anticonvulsant, hypnotic, sedative, and skeletal muscle relaxant effects. It is considered pharmacologically similar to other short-acting hypnotic benzodiazepines such as triazolam and midazolam.
Pharmacokinetics
Brotizolam is rapidly absorbed following administration and is rapidly eliminated, with an average half-life of 4.4 hours (range 3.6–7.9 hours).citation needed It is metabolized into two primary metabolites: a 4-hydroxy derivative with far less potency than the parent compound, and a 1-methylhydroxy derivative thought to have comparable activity. However, the 1-methylhydroxy metabolite is not present in measurable plasma concentrations following a single dose in healthy subjects, so neither metabolite contributes significantly to the overall pharmacological effect in humans.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
Benzodiazepines, Thienodiazepines, Other GABA-A positive allosteric modulators
Harm Potential
Addiction & Dependence
Psychological
ModerateBrotizolam has recognized potential for abuse and is classified as habit-forming.citation needed Abuse was significant enough in Hong Kong during the late 1980s and 1990s to warrant government reclassification as a Dangerous Drug, with regulatory controls subsequently extended to all benzodiazepines.
Physical
ModeratePhysical dependence can develop with regular use.1 Treatment is recommended for only 2-4 weeks for severe insomnia.citation needed Mild rebound insomnia may occur when treatment is stopped, indicating physiological adaptation to the drug.
Psychosis Risk
Hallucinations and paradoxical reactions including aggression, anxiety, and violent behavior are listed as less common side effects.citation needed These psychiatric disturbances appear to be uncommon at recommended doses.
History & Culture
Development and Commercialization
Brotizolam was first patented in 1974.citation needed The compound's synthesis was subsequently documented by Weber, Bauer, Danneberg, and Kuhn through a 1978 United States patent. The substance entered clinical practice a decade after its initial patent in 1984, finding adoption
Legality
By Country
References
Source Pages
Citations
- Lendormin 0.25mg tablets (Brotizolam) – Core Safety Profile, European PSUR Work Sharing Project. College ter Beoordeling van Geneesmiddelen (CBG-MEB) (2009). https://db.cbg-meb.nl/veegactie/csp/brotizolam-3-2009.pdf1
- Kenneth K.C. Lee, Thomas Y.K. Chan, Anthony W.K. Chan, Grace S.N. Lau, & Julian A.J.H. Critchley. (1995). Use and abuse of benzodiazepines in Hong Kong 1990-1993--the impact of regulatory changes. Journal of Toxicology. Clinical Toxicology, 33(6), 597–602. https://doi.org/10.3109/155636595090106151234
- European Medicines Agency. (2023-07-06). List of nationally authorised medicinal products: brotizolam, Procedure No. PSUSA/00000444/202212. European Medicines Agency. https://www.ema.europa.eu/en/documents/psusa/brotizolam-list-nationally-authorised-medicinal-products-psusa00000444202212_en.pdf123456
- Royal Decree of 6 September 2017 regulating narcotic drugs and/or psychotropic substances, Annex III. ejustice.just.fgov.be (n.d.). http://www.ejustice.just.fgov.be/eli/arrete/2017/09/06/2017031231/justel1
- Royal Decree of 6 September 2017 regulating narcotic drugs and/or psychotropic substances, Annex III. afmps.be (n.d.). https://www.afmps.be/sites/default/files/content/INSP/NARC/annex%20III_non%20official%20consolidated%20version.pdf1
- Bulletin: Controlled Substances Licensed Dealers Regulations — Benzodiazepines and Other Targeted Substances. canada.ca (n.d.). https://www.canada.ca/en/health-canada/services/health-concerns/reports-publications/controlled-substances-precursor-chemicals/bulletin-controlled-substances-licensed-dealers-regulations-benzodiazepines-other-targeted-substances.html1
- German Federal Government. (n.d.). Betäubungsmittelgesetz (BtMG) – Anlage III (zu § 1 Abs. 1): verkehrsfähige und verschreibungsfähige Betäubungsmittel. gesetze-im-internet.de. https://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html1
- Betäubungsmittelgesetz § 13 Verschreibung und Abgabe auf Verschreibung. gesetze-im-internet.de (n.d.). https://www.gesetze-im-internet.de/btmg_1981/__13.html1
- Pharmacy Society of Hong Kong. (2011). Consolidated List of Poisons, Antibiotics and Dangerous Drugs – Schedule 1, Part I Dangerous Drugs (Cap.134). Hong Kong Pharmaceutical Journal, 18(4 (Supplement)). http://www.pshk.hk/uploads/files/HKPJ/v18n4supp.pdf1
- Pharmacists Ordinance [New Version], 1981 (official government PDF). gov.il (n.d.). https://www.gov.il/BlobFolder/service/application-for-cosmetic-import-permits/en/pkudat-rokhim.pdf1
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass review
A first pass manual review and edit of article prose and copy has been performed by subject-matter expert Lyrea. This does not guarantee factual accuracy. An additional human review for each of this article's citations is yet to be performed.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes8 human edits · latest
Times are UTCNewest first
19 August 2026
Lyrea · Changed a word in Subjective Effects › Notes › Overview
Lyrea · Changed a word in Dosage & Duration › Routes 1 › Dose ranges › Threshold
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Brotizolam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.